Clinical Trials Register Can Benefit to Mesothelioma Patients
EU clinical trials register before site recently were to apply, to track and monitor thousands of patients including medical studies. The site will be maintained by the European Medicines Agency, tracking status and update information to the public. Already, seven thousand trials include the site listed.
An estimated ten thousand clinical studies are one at any time is. These tests offer a chance to experience new treatments to patients with various diseases and benefit from the top of the technology advances. Many diseases have no known cure – these studies advanced medical opportunities for researchers, scientists, to help service providers and patients, to offer all illnesses curable.
Such a disease without known cure is rarely cancer mesothelioma. Mesothelioma affects every year and an approximately ten to twenty thousand people about three thousand Americans around the world. The WHO estimates that mesothelioma cases are on the rise, 490 000 annually worldwide. This has much to do with the cause of mesothelioma, toxic chemical asbestos.
Asbestos was used so much in the United States between the 1920s and 1980s, that it the nickname “Backbone of the American industry.” Known as the health hazards of asbestos reduced use. At the time which regulates environmental protection agency asbestos use and removal of public health and safety. However there is asbestos is, so many buildings, structures, machinery and equipment, that exposure is by no means impossible.
Once inhaled or ingested or if they penetrate the skin they can asbestos fibres a mutative in the lining of the stomach cavities start. In most cases in the lungs show developed lining, this process over the decades, often under twenty to fifty years recognizable symptoms. Many mesothelioma patients have no idea that they have cancer, are exhausted to other symptom-related opportunities. Once a correct diagnosis is made, life expectancy ranges from six months to two years. Mesothelioma treatments include surgery, chemotherapy and radiation therapy.
With EU clinical trials register website currently lists sixteen mesothelioma related tests, including: “phase I / II study of cisplatin and Pemetrexed +/-sorafenib in malignant pleural mesothelioma”, and “treatment of malignant mesothelioma with Pemetrexed (Alimta) + Platinum (4 courses) or Pemetrexed (Alimta) + Platinum (4 courses), followed by/caelyx single drug (4 courses).”
European Commissioner for health and consumer protection, John Dalli, told the website: “the register started is good news for patients like it simpler details of clinical trials, which will enable them in the EU, may have access to important new treatment.” “It is for health professionals and carers, research and industry of interest.”
This entry was posted on Tuesday, April 5th, 2011 at 6:55 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Ping is currently not allowed.